Fleury S.A. is one of Brazil's largest medical diagnostics companies, built from a single laboratory founded in 1926 into a national network that now also runs fertility clinics, infusion centers, and ophthalmology services. Full nameFleury S.A. Tickers / exchangeFLRY3 / B3 (São Paulo) HeadquartersSão Paulo, SP, Brazil SectorHealthcare — Diagnostics & Research Employees28,000 Market valueR$ 11.62 billion (US$ 2.26 billion) Yearly salesR$ 8.79 billion (US$ 1.71 billion) Net profitR$ 612.8 million (US$ 119.2 million) Net margin8.0% Return on equity12.6% Price-to-earnings18.4 Dividend yield5.6% Websiteri.fleury.com.br What it is Fleury is a healthcare …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Latest coverage
Brazil Q2 Earnings: Fleury Profit Jumps 46%; Energisa Swings to Loss
Fleury Closes $41m Femme Buy to Build Brazil’s Women’s-Health Network
Fleury Q1 Profit +12% Beats Consensus in Centennial Year
Brazil’s Fleury Grows Profit 15% as Diagnostics Revenue Climbs
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →